#SARS-CoV-2

Treatment with interferon beta-1a plus the antiviral remdesivir was not superior to remdesivir alone.

Many people who received any of the authorized COVID-19 vaccines will be eligible for an additional dose.

Co-occurring health disorders appear to contribute to increased risk, NIH study suggests.

People who received the Moderna COVID-19 vaccine had strong immune memory of SARS-CoV-2 six months after vaccination.

Molnupiravir reduces severe illness and death, but it must be started within days after developing symptoms.

The Flowflex COVID-19 Home Test adds to the growing list of tests that can be used at home without a prescription.

A steady stream of spurious claims about COVID-19 vaccines and treatments swirl around the public consciousness.

Mask guidance has been mixed since the dawn of the pandemic, and new research has altered conventional thinking.

Recommendation includes people over 65, those with underlying medical conditions and those with occupational risk.

Third booster dose may improve immune response in cancer patients without sufficient protection after second dose.

Third dose OK’d for people over 65, those at risk for severe COVID-19 and those at high risk of exposure to the coronavirus.

About half of people hospitalized with COVID-19 had antibodies that could mistakenly attack the body’s own proteins and tissues.

The committee voted against third shot for all adults, however, casting doubts on Biden’s booster plan.

Antibodies that mistakenly target the body’s own immune-system proteins may account for about 20% of COVID-19 deaths.

Certain types of cancer treatment can lead to inadequate immune response.